Article Figures & Data
Figures
- Figure 1.
Curcumin concentration- and time-dependently inhibited cell proliferation, protein/DNA synthesis, and Akt/mTOR signaling in PC-3 cells. A, cells were treated with various concentrations of curcumin in serum-free media for certain period then the cell viability (after 24 h), protein synthesis and DNA synthesis (after 8 h) were measured by MTS assay, 3H-Leu and 3H-TdR incorporation, respectively. B, cells were treated with 50 μM of curcumin for indicated time, then the protein and DNA synthesis were measured by 3H-Leu and 3H-TdR incorporation, respectively. The results are presented as percentage of untreated control and each value is the mean ± SD of 4 parallel samples. C and D, cells were treated with indicated concentrations of curcumin or DMSO (control) in serum-free media for indicated time, then harvested and immuno-blotted against indicated proteins using their phosphor-specific antibodies. Actin was blotted as a loading control. Please note that two isoforms of S6K were visualized but the p85 isoform was not affected by curcumin.
- Figure 2.
A, PIP3 rescued PI3K inhibitor LY294002-mediated but not curcumin-mediated inhibition of Akt/mTOR signaling in PC-3 cells. Cells were incubated with 40 μM of curcumin or 15 μM of LY294002 in the presence of increasing concentrations of PIP3 for 1 h, then harvested and the indicated proteins were blotted. B, curcumin did not inhibit PDK1 activity towards Akt. 1 μg of purified His-tagged Akt1 protein was incubated with 50 ng of purified active PDK1 (PDK1Δ52) in the presence of indicated concentrations of curcumin in kinase assay buffer/1 mM ATP for 20 min, then phosphor-Akt T308 and PDK1 were immuno-blotted.
- Figure 3.
Overexpression of HA-Akt or myr-HA-Akt only partially rescued curcumin-mediated inhibition in PC-3 cells. A, cells were transfected with equal amount of indicated plasmids for 24 h, serum-starved for 12 h, then treated with various concentrations of curcumin in serum-free media for 1 h, and harvested and blotted against indicated proteins. B, cells were transfected with equal amount of indicated plasmids for 24 h, then treated with 40 μM of curcumin in serum-free media for 4 h, and harvested and blotted against cyclin D1 or actin. C, cells were transfected with equal amount of indicated plasmids for 24 h, and then treated with various concentrations of curcumin in serum-free media for 24 h, and the cell viability was determined by MTS assay. The results are presented as percentage of untreated control and each value is the mean ± SD of 4 parallel samples. The difference between vector and HA-Akt or myr-HA-Akt is verified by t test. *, P < 0.05; **, P < 0.01.
- Figure 4.
Activation of AMPK is not the major reason for curcumin-mediated inhibition of mTOR signaling in PC-3 cells. A, cells were pretreated with 10 μM of compound C for 15 min then treated with 40 μM of curcumin in the presence of compound C for 1 h, then harvested and blotted against indicated proteins. B, cells were transfected with indicated plasmids for 24 h, then harvested and blotted against HA, phosphor-ACC and actin. NS: Non-specific band. C, cells were transfected with indicated plasmids for 24 h, serum-starved for 12 h and then treated with various concentrations of curcumin in serum-free media for 1 h, and harvested and blotted against indicated proteins.
- Figure 5.
Disruption of TSC1-TSC2 complex failed to rescue curcumin-mediated inhibition of mTOR signaling. A, wild type or TSC1 (−/−) MEFs were serum-starved for 12 h then incubated with various concentrations of curcumin in serum-free media for 1 h, and harvested and blotted against indicated proteins. B, PC-3 cells were transfected with siRNA against TSC2/tuberin or scrambled control RNA for 48 h, serum-starved for 12 h, then treated with 40 μM of curcumin in serum-free media for 1 h, and harvested and blotted against proteins indicated.
- Figure 6.
Curcumin-mediated inhibition of Akt/mTOR signaling in PC-3 cells is dependent on PP2A and/or unspecified calyculin A-sensitive protein phosphatase activity. A, cells were pretreated with indicated concentrations of protein phosphatase inhibitors for 15 min, then incubated with 40 μM of curcumin in the presence of protein phosphatase inhibitors in serum-free media for 1 h, and harvested and blotted against indicated proteins. B and C, cells were pretreated with 100 nM of calyculin A for 15 min, then incubated with 40 μM of curcumin in the presence of calyculin A for 4 h, and then (B) cells were harvested and blotted against cyclin D1 and actin or (C) 3H-Leu incorporation was determined as described in Material and Methods. D, cells were treated with indicated concentrations of curcumin for 10 min, then harvested in phosphatase lysis buffer and the protein phosphatase activities in lysates were determined as described in Material and Methods. The results are expressed as mean ± SD of 4 parallel samples. *, P < 0.05; **, P < 0.01.
- Figure 7.
Summary of the mechanisms by which curcumin inhibits Akt/mTOR signaling and cell survival/proliferation in PC-3 prostate cancer cells. Curcumin activated PP2A and/or unspecified calyculin A-sensitive protein phosphatase activities towards Akt, mTOR, led to the dephosphorylation of Akt/mTOR and their downstream substrates GSK3, FoxO1, p70S6K and 4E-BP1, and finally inhibited the expression of proteins that are essential for cell survival and proliferation. Curcumin also activated MAPKs and AMPK; however these kinases did not play important roles in the curcumin-mediated inhibition of Akt/mTOR signaling and cell proliferation.
Volume 7, Issue 9
